RNA icon

Avidity Biosciences

148 hedge funds and large institutions have $1.57B invested in Avidity Biosciences in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 21 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+21
Holders Change %
+16.54%
% of All Funds
2.39%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
41
Increased
75
Reduced
21
Closed
18
Calls
$3.1M
Puts
$5.51M
Net Calls
-$2.41M
Net Calls Change
-$4.69M
Name Holding Trade Value Shares
Change
Shares
Change %
ACM
151
Altium Capital Management
New York
-$2.45M -150,000 Closed
TCM
152
Tekla Capital Management
Massachusetts
-$1.06M -64,618 Closed
BNP Paribas Financial Markets
153
BNP Paribas Financial Markets
France
-$711K -43,523 Closed
GCM
154
Graham Capital Management
Connecticut
-$582K -35,640 Closed
Qube Research & Technologies (QRT)
155
Qube Research & Technologies (QRT)
United Kingdom
-$486K -29,758 Closed
Walleye Trading
156
Walleye Trading
New York
-$379K -23,218 Closed
Victory Capital Management
157
Victory Capital Management
Texas
-$324K -19,842 Closed
PVI
158
Pura Vida Investments
New York
-$302K -18,506 Closed
VF
159
Virtu Financial
New York
-$298K -18,252 Closed
HS
160
HighVista Strategies
Massachusetts
-$283K -17,334 Closed
Los Angeles Capital Management
161
Los Angeles Capital Management
California
-$196K -12,025 Closed
Ensign Peak Advisors
162
Ensign Peak Advisors
Utah
-$187K -11,480 Closed
YIH
163
Y-Intercept (HK)
Hong Kong
-$172K -10,539 Closed
PHK
164
Point72 Hong Kong
Hong Kong
-$78K -4,804 Closed